Find stats on top websites
Major Markets
United States
Canada
United KingdomSelect a competitor
European Medicines Agency (EMA)
World Health Organization (WHO)
Centers for Disease Control and Prevention (CDC)
Top Marketing Channels
European Medicines Agency (EMA)
- Official Website & Publications
- Examples: ema.europa.eu, Regulatory Guidelines, Scientific Opinions
- Campaigns: Transparency Initiative, Public Consultations on Guidelines, Annual Work Programme Dissemination
- Press Releases & Media Relations
- Examples: EMA press office, Media briefings, Stakeholder engagement events
- Campaigns: New Drug Approval Announcements, Safety Updates for Medicines, Public Health Alerts
- Social Media & Webinars
- Examples: LinkedIn (EMA), Twitter (@EMA_News), YouTube (EMA Videos)
- Campaigns: EMA Human Medicines Highlights, Veterinary Medicines Information Day, Regulatory Science to 2025 Strategy Webinars
Top Sales Channels
- Regulatory Submissions Portal
- Centralised procedure applications, Orphan designation requests, Paediatric investigation plans submissions
- eSubmission Transition Support, Guideline for Regulatory Submissions, Harmonisation of Submission Formats
- Scientific Advice Services
- Pre-submission meetings, Scientific advice for novel therapies, Protocol assistance for orphan drugs
- Accelerated Assessment Pathway, PRIME Scheme Promotion, Scientific Advice for Advanced Therapy Medicinal Products
- Training & Workshops (for industry professionals)
- Regulatory affairs workshops, Clinical trial guidelines training, Pharmacovigilance seminars
- Good Manufacturing Practice (GMP) Training, Clinical Data Transparency Workshop, Regulatory Science Training Programme
U.S. Food and Drug Administration SWOT Analysis
Strengths
Centralized drug approval for EU
Strong scientific expertise
Transparent regulatory processes
Weaknesses
Bureaucratic processes can be slow
Dependent on member state cooperation
Language barriers for wider public engagement
Opportunities
Increased international collaboration
Adoption of new technologies for regulatory processes
Greater focus on real-world evidence
Threats
Brexit impact on regulatory landscape
Political pressures influencing decisions
Emergence of new unregulated health products
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
